Chemo's hidden toll: study probes life after endometrial cancer treatment

NCT ID NCT03466788

Completed Knowledge-focused Sponsor: Centre Francois Baclesse Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how chemotherapy impacts the quality of life of women treated for stage II or III endometrial cancer. Researchers asked 51 patients to fill out questionnaires about their physical, emotional, and social well-being at least two years after finishing treatment. The goal was to understand the long-term effects of chemotherapy beyond just survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors understand the long-term quality-of-life effects of chemotherapy for endometrial cancer, guiding better treatment decisions.
What could go wrong: This is a small, completed observational study with only 51 participants, so results may not apply to all patients. It relies on self-reported questionnaires, which can be subjective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY EFFECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chemotherapy-induced toxicity endometrial cancer endometrium adenocarcinoma endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHEMOTHERAPY EFFECT ENDOMETRIAL CANCER QUALITY OF LIFE

Contacts and locations

Show contact details

Locations

Centre Eugène Marquis

Rennes, France
Centre François Baclesse

Caen, 14076, France
Centre Henri Becquerel

Rouen, France
Centre Oscar Lambret

Lille, France
Institut Gustave Roussy

Villejuif, 94805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.